Your browser doesn't support javascript.
loading
Genetic insight into sick sinus syndrome.
Thorolfsdottir, Rosa B; Sveinbjornsson, Gardar; Aegisdottir, Hildur M; Benonisdottir, Stefania; Stefansdottir, Lilja; Ivarsdottir, Erna V; Halldorsson, Gisli H; Sigurdsson, Jon K; Torp-Pedersen, Christian; Weeke, Peter E; Brunak, Søren; Westergaard, David; Pedersen, Ole B; Sorensen, Erik; Nielsen, Kaspar R; Burgdorf, Kristoffer S; Banasik, Karina; Brumpton, Ben; Zhou, Wei; Oddsson, Asmundur; Tragante, Vinicius; Hjorleifsson, Kristjan E; Davidsson, Olafur B; Rajamani, Sridharan; Jonsson, Stefan; Torfason, Bjarni; Valgardsson, Atli S; Thorgeirsson, Gudmundur; Frigge, Michael L; Thorleifsson, Gudmar; Norddahl, Gudmundur L; Helgadottir, Anna; Gretarsdottir, Solveig; Sulem, Patrick; Jonsdottir, Ingileif; Willer, Cristen J; Hveem, Kristian; Bundgaard, Henning; Ullum, Henrik; Arnar, David O; Thorsteinsdottir, Unnur; Gudbjartsson, Daniel F; Holm, Hilma; Stefansson, Kari.
Afiliação
  • Thorolfsdottir RB; deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
  • Sveinbjornsson G; deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
  • Aegisdottir HM; deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
  • Benonisdottir S; deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
  • Stefansdottir L; deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
  • Ivarsdottir EV; deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
  • Halldorsson GH; deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
  • Sigurdsson JK; deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
  • Torp-Pedersen C; Department of Clinical Research and Cardiology, Nordsjaelland Hospital, Dyrehavevej 29, Hillerød 3400, Denmark.
  • Weeke PE; Department of Cardiology, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen 2100, Denmark.
  • Brunak S; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3A, Copenhagen 2200, Denmark.
  • Westergaard D; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3A, Copenhagen 2200, Denmark.
  • Pedersen OB; Department of Clinical Immunology, Naestved Hospital, Ringstedgade 77B, Naestved 4700, Denmark.
  • Sorensen E; Department of Clinical Immunology, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen 2100, Denmark.
  • Nielsen KR; Department of Clinical Immunology, Aalborg University Hospital North, Urbansgade 36, Aalborg 9000, Denmark.
  • Burgdorf KS; Department of Clinical Immunology, Copenhagen University Hospital, Blegdamsvej 9, Copenhagen 2100, Denmark.
  • Banasik K; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3A, Copenhagen 2200, Denmark.
  • Brumpton B; Department of Thoracic and Occupational Medicine, St. Olavs Hospital, Trondheim University Hospital, Prinsesse Kristinas gate 3, Trondheim 7030, Norway.
  • Zhou W; Department of Computational Medicine and Bioinformatics, University of Michigan, 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218, USA.
  • Oddsson A; deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
  • Tragante V; deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
  • Hjorleifsson KE; deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
  • Davidsson OB; Department of Computing and Mathematical Sciences, California Institute of Technology, 1200 E California Blvd. MC 305-16, Pasadena, CA 91125, USA.
  • Rajamani S; deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
  • Jonsson S; deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
  • Torfason B; deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
  • Valgardsson AS; Faculty of Medicine, University of Iceland, Vatnsmyrarvegur 16, Reykjavik 101, Iceland.
  • Thorgeirsson G; Department of Cardiothoracic Surgery, Landspitali-The National University Hospital of Iceland, Hringbraut, Reykjavik 101, Iceland.
  • Frigge ML; Department of Cardiothoracic Surgery, Landspitali-The National University Hospital of Iceland, Hringbraut, Reykjavik 101, Iceland.
  • Thorleifsson G; deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
  • Norddahl GL; Faculty of Medicine, University of Iceland, Vatnsmyrarvegur 16, Reykjavik 101, Iceland.
  • Helgadottir A; Department of Medicine, Landspitali-The National University Hospital of Iceland, Hringbraut, Reykjavik 101, Iceland.
  • Gretarsdottir S; deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
  • Sulem P; deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
  • Jonsdottir I; deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
  • Willer CJ; deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
  • Hveem K; deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
  • Bundgaard H; deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
  • Ullum H; deCODE genetics/Amgen, Inc., Sturlugata 8, Reykjavik 101, Iceland.
  • Arnar DO; Faculty of Medicine, University of Iceland, Vatnsmyrarvegur 16, Reykjavik 101, Iceland.
  • Thorsteinsdottir U; Department of Immunology, Landspitali-The National University Hospital of Iceland, Hringbraut, Reykjavik 101, Iceland.
  • Gudbjartsson DF; Department of Computational Medicine and Bioinformatics, University of Michigan, 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218, USA.
  • Holm H; Department of Internal Medicine: Cardiology, University of Michigan, 1500 East Medical Center Drive, Ann Arbor, MI 48109 -5368, USA.
  • Stefansson K; Department of Human Genetics, University of Michigan, 4909 Buhl Building, 1241 E. Catherine St., Ann Arbor, MI 48109 -5618, USA.
Eur Heart J ; 42(20): 1959-1971, 2021 05 21.
Article em En | MEDLINE | ID: mdl-36282123
ABSTRACT

AIMS:

The aim of this study was to use human genetics to investigate the pathogenesis of sick sinus syndrome (SSS) and the role of risk factors in its development. METHODS AND

RESULTS:

We performed a genome-wide association study of 6469 SSS cases and 1 000 187 controls from deCODE genetics, the Copenhagen Hospital Biobank, UK Biobank, and the HUNT study. Variants at six loci associated with SSS, a reported missense variant in MYH6, known atrial fibrillation (AF)/electrocardiogram variants at PITX2, ZFHX3, TTN/CCDC141, and SCN10A and a low-frequency (MAF = 1.1-1.8%) missense variant, p.Gly62Cys in KRT8 encoding the intermediate filament protein keratin 8. A full genotypic model best described the p.Gly62Cys association (P = 1.6 × 10-20), with an odds ratio (OR) of 1.44 for heterozygotes and a disproportionally large OR of 13.99 for homozygotes. All the SSS variants increased the risk of pacemaker implantation. Their association with AF varied and p.Gly62Cys was the only variant not associating with any other arrhythmia or cardiovascular disease. We tested 17 exposure phenotypes in polygenic score (PGS) and Mendelian randomization analyses. Only two associated with the risk of SSS in Mendelian randomization, AF, and lower heart rate, suggesting causality. Powerful PGS analyses provided convincing evidence against causal associations for body mass index, cholesterol, triglycerides, and type 2 diabetes (P > 0.05).

CONCLUSION:

We report the associations of variants at six loci with SSS, including a missense variant in KRT8 that confers high risk in homozygotes and points to a mechanism specific to SSS development. Mendelian randomization supports a causal role for AF in the development of SSS.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur Heart J Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Islândia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Diabetes Mellitus Tipo 2 Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Eur Heart J Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Islândia